Mechanisms and models of TDP-43 proteinopathies

Results
To explore the pathogenic properties of mutant forms of TDP-43, we generated and characterized two mouse lines expressing human TDP-43 carrying the M337V mutation (hTDP-43 M337V ). We found hTDP-43 M337V was expressed primarily in the nuclei of neurons in the brain and spinal cord, intranuclear and cytoplasmic phosphorylated TDP-43 aggregates were frequently detected, and the levels of TDP-43 LMW products of~25 kDa and~35 kDa species were also increased. Overexpression of hTDP-43 M337V dramatically down regulated the levels of mouse TDP-43 (mTDP-43) protein and RNA, indicating TDP-43 levels are tightly controlled in mammalian systems. TDP-43 M337V mice displayed reactive gliosis, widespread ubiquitination, chromatolysis, gait abnormalities, and early lethality. Abnormal cytoplasmic mitochondrial aggregates and abnormal phosphorylated tau were also detected in the mice.
Conclusion
While overexpression of hTDP-43 in wild-type TDP-43 and TDP-43 M337V mouse models produces similar phenotypes, our results suggest that overexpression of the hTDP-43 M337V can cause neuronal dysfunction due to its effect on a number of cell organelles and proteins, such as mitochondria and TDP-43, that are critical for neuronal activity.
